Cytoreductive surgery in the management of metastatic renal cell carcinoma: The UCLA experience

Seminars in Urologic Oncology

Volumn 14, Issue 4, 1996, Pages 230-236

  Franklin, J R ^a   Figlin, R ^a   Rauch, J ^a   Gitlitz, B ^a   Belldegrun, A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytoreductive nephrectomy; immunotherapy; renal carcinoma

Indexed keywords

INTERLEUKIN 2; RECOMBINANT ALPHA2A INTERFERON;

ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHRECTOMY; PARTIAL HEPATECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SPLENECTOMY; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CALIFORNIA; CARCINOMA, RENAL CELL; COMBINED MODALITY THERAPY; EVALUATION STUDIES; FEMALE; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-2; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEPHRECTOMY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0029957639     PISSN: 10810943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)